Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Alectinib versus chemotherapy in crizotinib-pretreated anaplastic lymphoma kinase (ALK)-positive non-small-cell lung cancer: results from the phase III ALUR study
PaperCitations, authors & open-access status
Alectinib versus chemotherapy in crizotinib-pretreated anaplastic lymphoma kinase (ALK)-positive non-small-cell lung cancer: results from the phase III ALUR study is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 346 citations, 2018 year and bronze oa status.
346
Citations
2018
Year
bronze
OA Status